Related references
Note: Only part of the references are listed.Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
Barbara Romano et al.
PHYTOMEDICINE (2014)
Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions
Constantinos Giaginis et al.
TUMOR BIOLOGY (2014)
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
Thomas J. W. Klein Nulent et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2013)
Receptor-dependent and receptor-independent endocannabinoid signaling: A therapeutic target for regulation of cancer growth
Rukiyah Van Dross et al.
LIFE SCIENCES (2013)
The endocannabinoid signaling system in cancer
Simona Pisanti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
Chan Kwon Jung et al.
ONCOLOGY LETTERS (2013)
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
Gabriella Aviello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Why do cannabinoid receptors have more than one endogenous ligand?
Vincenzo Di Marzo et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
Anju Preet et al.
CANCER PREVENTION RESEARCH (2011)
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
Li Huang et al.
LABORATORY INVESTIGATION (2011)
The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications
Lydia K. Miller et al.
PHARMACOLOGICAL REVIEWS (2011)
Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation?
Elizabeth M. Ward et al.
FUTURE ONCOLOGY (2010)
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis
Rosanna Cozzolino et al.
INVESTIGATIONAL NEW DRUGS (2010)
The Synthetic Cannabinoid WIN 55,212-2 Sensitizes Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis by Activating p8/CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)/Death Receptor 5 (DR5) Axis
O. Pellerito et al.
MOLECULAR PHARMACOLOGY (2010)
Evaluation of FAK and Src Expression in Human Benign and Malignant Thyroid Lesions
Christina Michailidi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
R. Michael Tuttle et al.
THYROID (2010)
An introduction to the endocannabinoid system: from the early to the latest concepts
Luciano De Petrocellis et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil
Sofia B. Gustafsson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
Sui Chu Chung et al.
EUROPEAN JOURNAL OF CANCER (2009)
Cannabinoids in pancreatic cancer:: Correlation with survival and pain
Christoph W. Michalski et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma
Y. Shi et al.
CANCER GENE THERAPY (2008)
Thyroid nodules: Clinical importance, assessment, and treatment
Hossein Gharib et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2007)
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xundi Xu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway
Blanca Herrera et al.
EXPERIMENTAL CELL RESEARCH (2006)
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
Arkaitz Carracedo et al.
CANCER RESEARCH (2006)
Anandamide inhibits adhesion and migration of breast cancer cells
C Grimaldi et al.
EXPERIMENTAL CELL RESEARCH (2006)
Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus
P Derkinderen et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Share Paper
